Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Depreciation & Amortization (CF) (2011 - 2026)

Updated

Grace Therapeutics (GRCE) reported Depreciation & Amortization (CF) of $1,000 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 50.0% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Grace Therapeutics' Depreciation & Amortization (CF) came in at $8,000, up 33.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $7,000, unchanged from FY2025.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of -45.3% (FY2021 to FY2026).
  • By fiscal year, Depreciation & Amortization (CF) came in at $7,000 in FY2025 (-36.4%), $11,000 in FY2024 (-91.1%) and $124,000 in FY2023.
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of -$61,000 in fiscal Q2 2023 and a high of $167,000 in fiscal Q1 2023.
  • Year over year, Depreciation & Amortization (CF) gained in four of the last six quarters, with growth averaging 58.3%.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was fiscal Q1 2026 (growth of 100.0%); the low point was fiscal Q1 2024 (a decline of 95.8%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $2,000 (Q1 2027), $2,000 (Q4 2026) and $3,000 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.12 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 192.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.61 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.58 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1,000.00
Jun 30, 2026 2,000.00
Mar 31, 2026 2,000.00
Dec 31, 2025 3,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 1,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 2,000.00
Jun 30, 2023 7,000.00
Mar 31, 2023 8,000.00
Dec 31, 2022 10,000.00
Sep 30, 2022 -61,000.00
Jun 30, 2022 167,000.00
Mar 31, 2021 1,000.00
Sep 30, 2020 56,000.00
Jun 30, 2020 86,000.00
API Access

Grace Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=GRCE&period=max&api_key=YOUR_API_KEY